JCIの2022年11月に掲載されたAflibercept is more effective than bevacizumab at weaning neovascular age-related macular degeneration patients off therapyを読みました。https://www.jci.org/articles/view/159125
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
This website doesn't track the visitors or use any cookies. Made by Alex Barredo. Send your feedback to alex@barredo.es.
